Answers are grounded in this paper and cite their sources.
Diagnostic tool assesses benign functional adrenal cortical disorders, indicating a shift in minimal patient management.
68Ga DOTA-Pentixafor PET/CT is a valuable diagnostic and potentially therapeutic tool for benign functional adrenal cortical disorders such as PA, CS, and EAS, with the potential to establish a new standard in minimally invasive patient management.
No takes yet. Share an insight, caveat, or question.
Şahin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: